Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings-Reference-Cited by-同舟云学术

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings

Published:2017-10-19 Issue:12 Volume:92 Page:1362-1369
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Hampel Paul J.¹^ORCID,Chaffee Kari G.²^ORCID,King Rebecca L.³,Simonetto Douglas⁴,Larson Melissa C.²,Achenbach Sara²,Call Timothy G.⁵,Ding Wei⁵^ORCID,Kenderian Saad S.⁵,Leis Jose F.⁶,Chanan-Khan Asher A.⁷,Bowen Deborah A.⁵,Conte Michael J.⁵,Schwager Susan M.⁵,Hanson Curtis A.³,Slager Susan L.²,Kay Neil E.⁵,Shanafelt Tait D.⁵,Parikh Sameer A.⁵^ORCID

Affiliation:

1. Department of Internal Medicine; Mayo Clinic; Rochester Minnesota

2. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research; Mayo Clinic; Rochester Minnesota

3. Division of Hematopathology, Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota

4. Division of Gastroenterology and Hepatology, Department of Medicine; Mayo Clinic; Rochester Minnesota

5. Division of Hematology, Department of Medicine; Mayo Clinic; Rochester Minnesota

6. Department of Hematology and Oncology; Mayo Clinic; Phoenix Arizona

7. Division of Hematology and Oncology; Mayo Clinic; Jacksonville Florida

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hematology

Reference38 articles.

1. A clinical staging system for chronic lymphocytic leukemia: prognostic significance;Binet;Cancer.,1977

2. Clinical staging of chronic lymphocytic leukemia;Rai;Blood.,1975

3. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis;Binet;Cancer.,1981

4. Prognostic factors and risk stratification in chronic lymphocytic leukemia;Parikh;Semin Oncol.,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update;Annals of Hematology;2024-07-25

2. Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests;Expert Opinion on Drug Safety;2024-04-02

3. Associations between serum levels of liver function biomarkers and all-cause and cause-specific mortality: A prospective cohort study;2023-09-26

4. Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia;Frontiers in Immunology;2022-09-02

5. Chronic Lymphocytic Leukemia Involving the Liver Without High-Grade Transformation;Annals of Internal Medicine: Clinical Cases;2022-09-01